Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.

Jung YH, Moon KC, Ha JW, Kim SJ, Ha IS, Cheong HI, Kang HG.

Pediatr Transplant. 2013 Mar;17(2):E50-4. doi: 10.1111/petr.12029. Epub 2012 Dec 4. Review.

PMID:
23210794
2.

Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.

Kim YJ, Jeong JC, Koo TY, Kwon HY, Han M, Jeon HJ, Ahn C, Yang J.

J Korean Med Sci. 2013 Dec;28(12):1711-5. doi: 10.3346/jkms.2013.28.12.1711. Epub 2013 Nov 26.

3.

Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.

Araya CE, Garin EH, Neiberger RE, Dharnidharka VR.

Pediatr Transplant. 2010 Feb;14(1):145-50. doi: 10.1111/j.1399-3046.2009.01183.x. Epub 2009 Mar 31.

PMID:
19344337
4.

[Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].

Materne C, Gerth J, Ott U, Gröne HJ, Wolf G.

Med Klin (Munich). 2009 Aug;104(8):644-8. doi: 10.1007/s00063-009-1136-1. Epub 2009 Aug 23. German.

PMID:
19701735
5.

Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.

Wu JK, Harris MT.

Ann Pharmacother. 2008 Nov;42(11):1679-85. doi: 10.1345/aph.1L180. Epub 2008 Oct 28. Review.

PMID:
18957628
6.

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.

Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D.

Transplantation. 2003 Jan 15;75(1):105-12.

PMID:
12544881
7.

[BK virus infections in pediatric kidney transplant recipients].

Mutlu D, Sağlık I, Koyun M, Comak E, Mutlu E, Uslu Gökçeoğlu A, Cağla Doğan S, Dinçkan A, Akbaş SH, Akkaya B, Akman S, Süleymanlar G, Colak D.

Mikrobiyol Bul. 2013 Jul;47(3):461-71. Turkish.

8.

Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.

Duclos AJ, Krishnamurthi V, Lard M, Poggio E, Kleeman M, Winans C, Fatica R, Nurko S.

Transplant Proc. 2006 Dec;38(10):3666-72.

PMID:
17175362
9.

Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.

Faguer S, Hirsch HH, Kamar N, Guilbeau-Frugier C, Ribes D, Guitard J, Esposito L, Cointault O, Modesto A, Lavit M, Mengelle C, Rostaing L.

Transpl Int. 2007 Nov;20(11):962-9. Epub 2007 Jul 30.

10.

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.

Lee HM, Jang IA, Lee D, Kang EJ, Choi BS, Park CW, Choi YJ, Yang CW, Kim YS, Chung BH.

Korean J Intern Med. 2015 Nov;30(6):865-72. doi: 10.3904/kjim.2015.30.6.865. Epub 2015 Oct 30.

11.

Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.

Nickeleit V, Singh HK, Mihatsch MJ.

Curr Opin Nephrol Hypertens. 2003 Nov;12(6):599-605. Review.

PMID:
14564196
12.

Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.

Halim MA, Al-Otaibi T, Gheith O, Zkaria Z, Mosaad A, Said T, Nair P, Nampoory N.

Exp Clin Transplant. 2014 Dec;12(6):528-33.

13.

BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.

Akioka K, Okamoto M, Ushigome H, Nobori S, Kaihara S, Yoshimura N.

Int J Urol. 2008 Apr;15(4):369-71. doi: 10.1111/j.1442-2042.2008.01998.x.

14.

Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.

Araya CE, Lew JF, Fennell RS 3rd, Neiberger RE, Dharnidharka VR.

Pediatr Transplant. 2006 Feb;10(1):32-7.

PMID:
16499584
15.

Leflunomide for polyomavirus type BK nephropathy.

Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, Garfinkel M, Foster P, Atwood W, Millis JM, Meehan SM, Josephson MA.

N Engl J Med. 2005 Mar 17;352(11):1157-8. No abstract available.

16.

BK virus nephropathy in renal transplant patients in London.

White LH, Casian A, Hilton R, Macphee IA, Marsh J, Sweny P, Trevitt R, Frankel AH, Warrens AN; Pan-Thames Renal Audit Group..

Transplantation. 2008 Apr 15;85(7):1008-15. doi: 10.1097/TP.0b013e31816a32fc.

PMID:
18408582
17.

Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.

Cuellar-Rodriguez J, Stephany B, Poggio E, Mossad SB, Goldfarb D, Lard M, Askar M, Fatica R, Srinivas T, Braun W, Shoskes D, Flechner S, Schmitt SK, Shrestha R, Avery RK.

Clin Transplant. 2013 May-Jun;27(3):E230-6. doi: 10.1111/ctr.12110. Epub 2013 Apr 3.

PMID:
23551281
18.

[BK virus nephropathy in a kidney transplant recipient: a case report and literature review].

Hoshi A, Segawa T, Takahashi T, Nakamura E, Higashi S, Ito N, Yamamoto S, Kamoto T, Ogawa O.

Hinyokika Kiyo. 2006 Feb;52(2):119-23. Japanese.

19.

Severe crescentic BK virus nephropathy with favourable outcome in a transplanted patient treated with Leflunomide.

Mazzucco G, Costa C, Bergallo M, Segoloni GP, Monga G.

Clin Nephrol. 2008 Aug;70(2):163-7.

PMID:
18793533
20.

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.

Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA.

Clin J Am Soc Nephrol. 2007 Sep;2(5):1037-42. Epub 2007 Aug 16.

Supplemental Content

Support Center